Jorge G. Carrillo

Madrid, MD, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 112 publications

Blinded two-year longitudinal evaluation of SARS-CoV-2 antigenemia in long COVID.

Blinded two-year longitudinal evaluation of SARS-CoV-2 antigenemia in long COVID.

Journal: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases

Published: February 16, 2026

Blinded 2-Year Longitudinal Evaluation of SARS-CoV-2 Antigenemia in Long COVID.

Blinded 2-Year Longitudinal Evaluation of SARS-CoV-2 Antigenemia in Long COVID.

Journal: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases

Published: February 16, 2026

Optimized ACE2-Fc fusion proteins with picomolar neutralization activity against highly evolved SARS-CoV-2 variants.

Optimized ACE2-Fc fusion proteins with picomolar neutralization activity against highly evolved SARS-CoV-2 variants.

Journal: Protein science : a publication of the Protein Society

Published: October 17, 2025

Under the Radar: Immune Evasion, Pathogenesis and Control of HIV Infection.

Under the Radar: Immune Evasion, Pathogenesis and Control of HIV Infection.

Journal: International journal of molecular sciences

Published: October 16, 2025

Pediatric long COVID is characterized by myeloid CCR6 suppression and immune dysregulation.

Pediatric long COVID is characterized by myeloid CCR6 suppression and immune dysregulation.

Journal: JCI insight

Published: October 09, 2025

IgD from atypical-like memory B cells and plasma cells targets commensal and environmental antigens.

IgD from atypical-like memory B cells and plasma cells targets commensal and environmental antigens.

Journal: The Journal of experimental medicine

Published: August 26, 2025

A human-ACE2 knock-in mouse model for SARS-CoV-2 infection recapitulates respiratory disorders but avoids neurological disease associated with the transgenic K18-hACE2 model.

A human-ACE2 knock-in mouse model for SARS-CoV-2 infection recapitulates respiratory disorders but avoids neurological disease associated with the transgenic K18-hACE2 model.

Journal: mBio

Published: April 24, 2025

Recurrent waning of anti-SARS-CoV-2 neutralizing antibodies despite multiple antigen encounters.

Recurrent waning of anti-SARS-CoV-2 neutralizing antibodies despite multiple antigen encounters.

Journal: Journal of translational medicine

Published: March 07, 2025

Anti-SARS-CoV-2 antibodies from severe COVID-19 individuals or S2 immunizations do not worsen disease in hamsters.

Anti-SARS-CoV-2 antibodies from severe COVID-19 individuals or S2 immunizations do not worsen disease in hamsters.

Journal: Communications biology

Published: January 15, 2025

Correction for Morón-López et al., "Comparison of Reverse Transcription (RT)-Quantitative PCR and RT-Droplet Digital PCR for Detection of Genomic and Subgenomic SARS-CoV-2 RNA".

Correction for Morón-López et al., "Comparison of Reverse Transcription (RT)-Quantitative PCR and RT-Droplet Digital PCR for Detection of Genomic and Subgenomic SARS-CoV-2 RNA".

Journal: Microbiology spectrum

Published: October 30, 2024

NSGS mice humanized with cord blood mononuclear cells show sustained and functional myeloid-lymphoid representation with limited graft-versus-host disease.

NSGS mice humanized with cord blood mononuclear cells show sustained and functional myeloid-lymphoid representation with limited graft-versus-host disease.

Journal: Journal for immunotherapy of cancer

Published: September 16, 2024

NK cell depletion in bispecific antibody therapy is associated with lack of HIV control after ART interruption.

NK cell depletion in bispecific antibody therapy is associated with lack of HIV control after ART interruption.

Journal: Communications biology

Published: September 04, 2024

Showing 1-12 of 112

Last Updated: 09/26/2026